{"id":2910,"date":"2016-05-17T14:30:33","date_gmt":"2016-05-17T18:30:33","guid":{"rendered":"https:\/\/medicarereport.org\/?p=2910"},"modified":"2016-05-17T14:30:33","modified_gmt":"2016-05-17T18:30:33","slug":"three-firms-vie-to-run-drug-benefits-for-california-public-retirement-system","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=2910","title":{"rendered":"Three Firms Vie To Run Drug Benefits For California Public Retirement System"},"content":{"rendered":"<p>(By Chad Terhune for Kaiser Health News)<\/p>\n<p>Three industry heavyweights are vying to run the prescription-drug business for one of the nation\u2019s biggest health-care buyers, the California Public Employees\u2019 Retirement System.<\/p>\n<p>Express Scripts and UnitedHealth Group\u2019s OptumRx unit are each trying to unseat the current pharmacy-benefits contractor, CVS Health. The stakes are high for the companies and CalPERS, which is struggling along with many employers nationwide to contain fast-rising drug costs. <a href=\"http:\/\/khn.org\/news\/three-firms-vie-to-run-calpers-drug-benefits\/?utm_campaign=KHN%3A+Daily+Health+Policy+Report&amp;utm_source=hs_email&amp;utm_medium=email&amp;utm_content=29654429&amp;_hsenc=p2ANqtz-9LTS8xAyHsE-AHbNH1B86M7WBScnEKbDIezq5AuAWcmwXrb3lqX25j_TLR2tLa0EUtorveGkxdwmyteMSydu6VyKkGMQ&amp;_hsmi=29654429\" target=\"_blank\">Read article here&#8230;&#8230;<\/a><\/p>\n<p style=\"font: 15px\/1.6 'Open Sans', serif; margin: 0px 0px 15px; padding: 0px; outline: 0px; border: 0px currentColor; color: #444444; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; vertical-align: baseline; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: inherit; background-color: #ffffff; -webkit-text-stroke-width: 0px;\">Kaiser Health News\u00a0is\u00a0a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n<p style=\"font: 15px\/1.6 'Open Sans', serif; margin: 0px 0px 15px; padding: 0px; outline: 0px; border: 0px currentColor; color: #444444; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; vertical-align: baseline; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: inherit; background-color: #ffffff; -webkit-text-stroke-width: 0px;\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-899 \" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png\" alt=\"khn-logo1\" width=\"92\" height=\"48\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-1024x533.png 1024w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-390x205.png 390w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png 1600w\" sizes=\"auto, (max-width: 92px) 100vw, 92px\" \/><\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Chad Terhune for Kaiser Health News) Three industry heavyweights are vying to run the prescription-drug business for one of<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-2910","post","type-post","status-publish","format-standard","hentry","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/2910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2910"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/2910\/revisions"}],"predecessor-version":[{"id":2911,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/2910\/revisions\/2911"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2910"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2910"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}